EYE PCR's fixOflex Endocapsular Device Achieves CE Mark for European Market Expansion EYE PCR has announced the successful acquisition of the CE Mark for its fixOflex endocapsular device, enabling its entry into the European market and beyond. This advancement reflects the device's proven safety and efficacy.

EYE PCR's fixOflex Endocapsular Device Achieves CE Mark for European Market Expansion #Greece #CE_Mark #EYE_PCR #fixOflex #Heraklion

EYE PCR Achieves CE Mark Approval for fixOflex Endocapsular Device, Opening European Market Access EYE PCR has successfully received CE Mark certification for its fixOflex endocapsular device, enabling its entry into the European market and confirming its safety and efficacy.

EYE PCR Achieves CE Mark Approval for fixOflex Endocapsular Device, Opening European Market Access #Greece #CE_Mark #EYE_PCR #fixOflex #Heraklion

EYE PCR's fixOflex Device Receives CE Mark, Enabling European Market Launch EYE PCR has achieved CE certification for its fixOflex endocapsular device, confirming its safety and enabling market introduction across Europe.

EYE PCR's fixOflex Device Receives CE Mark, Enabling European Market Launch #Greece #CE_Certification #EYE_PCR #fixOflex #Heraklion

EYE PCR Achieves CE Mark Certification for fixOflex Endocapsular Device, Opening Doors to European Market EYE PCR's fixOflex endocapsular device gains CE certification, ensuring its market entry in Europe and validating its clinical efficacy.

EYE PCR Achieves CE Mark Certification for fixOflex Endocapsular Device, Opening Doors to European Market #Greece #CE_Mark #EYE_PCR #fixOflex #Heraklion